Literature DB >> 14625471

Regulation of Fas (APO-1, CD95) and Fas ligand expression in leukocytes during systemic inflammation in humans.

Claudia Marsik1, Thomas Halama, Francesco Cardona, Wilhelm Wlassits, Florian Mayr, Johannes Pleiner, Bernd Jilma.   

Abstract

A potential role of Fas/FasL in sepsis is suggested by recent clinical studies showing that Fas and FasL could serve as markers for severity of sepsis. We sought to determine the effect of endotoxin infusion on expression of Fas and FasL. Healthy volunteers (n = 30) received 2 ng/kg endotoxin i.v. Endotoxin infusion decreased Fas expression on neutrophils and monocytes by 15-20% at 2-4 h in vivo and also in vitro. A rebound increase in Fas (30%) was seen on neutrophils at 24 h, and soluble FasL levels increased by 100% at 24 h. Fas mRNA levels increased 6-fold 4-6 h after endotoxin infusion as measured by real-time polymerase chain reaction. In contrast, FasL-mRNA levels in circulating leukocytes decreased by >80% 2h after lipopolysaccharide infusion. In summary, low-grade endotoxemia induces early down-modulation of Fas on leukocytes, followed by a several-fold increase in Fas-mRNA expression leading to later Fas surface upregulation on neutrophils. The upregulation of Fas expression, Fas mRNA, and later in FasL and sFas levels in endotoxemia replicates the increased fas levels found in septic patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14625471     DOI: 10.1097/01.shk.0000097248.97298.ea

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  5 in total

1.  Host derived biomarkers of inflammation, apoptosis, and endothelial activation are associated with clinical outcomes in patients with bacteremia and sepsis regardless of microbial etiology.

Authors:  William O Hahn; Carmen Mikacenic; Brenda L Price; Susanna Harju-Baker; Ronit Katz; Jonathan Himmelfarb; Mark M Wurfel; W Conrad Liles
Journal:  Virulence       Date:  2016-01-28       Impact factor: 5.882

2.  Genetic variation in the FAS gene and associations with acute lung injury.

Authors:  Bradford J Glavan; Tarah D Holden; Christopher H Goss; R Anthony Black; Margaret J Neff; Avery B Nathens; Thomas R Martin; Mark M Wurfel
Journal:  Am J Respir Crit Care Med       Date:  2010-09-02       Impact factor: 21.405

3.  In vivo delivery of caspase-8 or Fas siRNA improves the survival of septic mice.

Authors:  Doreen E Wesche-Soldato; Chun-Shiang Chung; Joanne Lomas-Neira; Lesley A Doughty; Stephen H Gregory; Alfred Ayala
Journal:  Blood       Date:  2005-06-07       Impact factor: 22.113

4.  Upregulation of the pro-apoptotic genes BID and FAS in septic shock patients.

Authors:  Fanny Turrel-Davin; Caroline Guignant; Alain Lepape; Bruno Mougin; Guillaume Monneret; Fabienne Venet
Journal:  Crit Care       Date:  2010-07-13       Impact factor: 9.097

5.  Increased serum soluble Fas after major trauma is associated with delayed neutrophil apoptosis and development of sepsis.

Authors:  Adnana Paunel-Görgülü; Sascha Flohé; Martin Scholz; Joachim Windolf; Tim Lögters
Journal:  Crit Care       Date:  2011-01-13       Impact factor: 9.097

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.